Early Phase 1 Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to give their informed consent to participate
- People who agree to use effective contraception during the trial
- People whose Body Mass Index (BMI) falls between 18.0 and 32.0
- People who are considered healthy based on a medical check-up and medical history
- People whose blood counts, iron levels, and related measures (including transferrin and ferritin) all fall within normal ranges, and whose transferrin saturation is normal and at least 20% (confirm with trial site)
- People who are able to swallow tablets and have veins that are suitable for taking blood samples
Who may not be able to join:
- People who have special dietary requirements that may be difficult to accommodate during the trial
- People who regularly use cannabis, or who have a history of illegal drug use within the past year
- People who have a history of alcohol abuse or binge drinking within the past 6 months
- People who regularly use tobacco or any products containing nicotine
- People who are unwilling or unable to follow the lifestyle guidelines set out in the trial protocol
- People who have a significant medical history or current condition affecting the heart, lungs, liver, kidneys, digestive system, hormones, nerves, immune system, or mental health, as determined by the trial doctor
- People who have any other disease, condition, or personal circumstance that the trial doctor considers would make participation unsuitable
- People who have received a blood transfusion within the past year
- People who have donated whole blood within the past 6 months, or donated plasma within the past 30 days
- People who require prescription medicines or who regularly take non-prescription medicines
- People who are employees of the trial sponsor, the research organisation running the trial, or any site involved in the study, or who are an immediate family member of someone employed at a trial site in a role connected to the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Aarthy Joseph, Dr, Nucleus Network
Phone: +61 07 3707 2787
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Number of Participants with Treatment-Emergent Adverse Events (TEAEs); Number of Participants with Serious TEAEs; Number of Participants with Clinically Significant Changes in Physical Examination; Number of Participants with Clinically Significant Changes in Safety Laboratory Values; Number of Participants with Clinically Significant Changes in Vital Signs; Number of Participants with Clinically Significant Changes in Electrocardiograms
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.